Table 4. Grade 3 or 4 AEs considered to be related to the Cidofovir and chemoradiotherapy combination (weeks 1 to 10) in the 15 patients.
| G3-4 AEs | Tota | Related to treatment |
|---|---|---|
| N (%) | N (%) | |
| Abdominal pain | 3 | 2 |
| Infection | 2 | 1 |
| Leukoneutropenia | 2 | 2 |
| Proteinuria | 1 | 1 |
| Myalgia | 1 | 0 |
| Vaginal bleeding | 1 | 0 |
| Asthenia | 1 | 0 |
| Insomnia | 1 | 0 |
| Hyperglycemia | 1 | 0 |
AEs: adverse events, N: number of patients.